Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes

OBJECTIVE: Diabetes has emerged as an important risk factor for mortality from COVID-19. Metformin, the most commonly prescribed glucose-lowering agent, has been proposed to influence susceptibility to and outcomes of COVID-19 via multiple mechanisms. We investigated whether, in patients with diabet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Endocrinol Metab
Autors principals: Wang, Jingya, Cooper, Jennifer M, Gokhale, Krishna, Acosta-Mena, Dionisio, Dhalla, Samir, Byne, Nathan, Chandan, Joht Singh, Anand, Astha, Okoth, Kelvin, Subramanian, Anuradhaa, Bangash, Mansoor N, Jackson, Thomas, Zemedikun, Dawit, Taverner, Tom, Hanif, Wasim, Ghosh, Sandip, Narendran, Parth, Toulis, Konstantinos A, Tahrani, Abd A, Surenthirakumaran, Rajendra, Adderley, Nicola J, Haroon, Shamil, Khunti, Kamlesh, Sainsbury, Christopher, Thomas, G Neil, Nirantharakumar, Krishnarajah
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Clinical Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928949/
https://ncbi.nlm.nih.gov/pubmed/33560344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgab067
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars